PLURYAL references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
Pluryal Hair Density
Pluryal Hair Density is a sterile, ready-to-use injectable polynucleotide (PN) biostimulator, CE-marked and reserved for medical practitioners only. Pluryal Hair Density polynucleotides are formulated for scalp and hair regeneration, indicated for hair loss conditions such as androgenetic alopecia and telogen effluvium, as well as post-hair transplantation support. The product contains 15 mg of polynucleotides per 2 mL syringe (7.5 mg/mL) and is intended strictly for professional use.
Key Benefits of Pluryal Hair Density
- Supports follicular stimulation through activation of dermal papilla cell activity
- Improves hair cycle dynamics, increasing the anagen/telogen ratio and reducing premature miniaturisation
- Provides anti-inflammatory action, reducing inflammatory mediators in the scalp
- Supports microcirculation, enhancing local perfusion, oxygenation and nutrient supply
- Promotes structural reinforcement around the follicle bulge, helping reduce hair shedding
- CE-marked medical device for professional use
Indications and Professional Use
Main indications
- Androgenetic alopecia
- Telogen effluvium
- Post-hair transplantation support
- Adjuvant therapy after hair transplantation
- Adjuvant therapy with LED light and PRP
Professional use
Pluryal Hair Density is for professional use only, reserved for medical practitioners. It is administered by intradermal injection into the scalp, using microbolus, multi-puncture or linear threading technique for diffuse areas. It is indicated for androgenetic alopecia, telogen effluvium, post-hair transplantation support, and as an adjuvant therapy after hair transplantation or alongside LED light and PRP treatment.
Treatment areas
- Scalp
- Eyebrows
- Beard
- Frontotemporal region
- Mid-scalp
- Vertex
Patient profile
Suitable for adult men and women presenting with androgenetic alopecia, telogen effluvium or scalp conditions requiring post-transplantation support, as determined by the treating practitioner following clinical assessment. The manufacturer cites a clinical study of 20 patients (10 men, 10 women; mean age 37.7 ± 8.1 years), diagnosed with androgenetic alopecia graded Hamilton-Norwood II to IV in men and Ludwig I to II in women, published in the Archives of Dermatological Research. Patients in that study received 10 intradermal injection sessions over 4 months; the manufacturer reports the study found a reduction in hair shedding, an increase in terminal hair count, and improvement in hair thickness and density parameters, with an excellent safety profile.
How Pluryal Hair Density Works
Pluryal Hair Density works through polynucleotides at 7.5 mg/mL, injected intradermally into the scalp to activate metabolic pathways and A2A purinergic receptors that promote dermal papilla cell activity. This supports improved hair cycle dynamics, reduces inflammatory mediators, enhances local microcirculation, and promotes structural reinforcement around the follicle bulge - together supporting scalp and hair regeneration in androgenetic alopecia, telogen effluvium and post-transplantation recovery.
Why Order From Allpara
Allpara offers genuine, verified PLURYAL products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
What concentration of polynucleotides does Pluryal Hair Density contain?
Pluryal Hair Density contains 15 mg of polynucleotides per 2 mL syringe, a concentration of 7.5 mg/mL, per the manufacturer.
Which areas does Pluryal Hair Density treat?
Pluryal Hair Density treats the scalp, eyebrows and beard, including the frontotemporal region, mid-scalp and vertex, for androgenetic alopecia, telogen effluvium and post-hair transplantation support.
At what depth is Pluryal Hair Density injected?
Pluryal Hair Density is injected intradermally into the scalp, using microbolus, multi-puncture or linear threading technique for diffuse areas, per the manufacturer.
Is there clinical evidence for Pluryal Hair Density?
The manufacturer cites a clinical study of 20 patients with androgenetic alopecia, published in the Archives of Dermatological Research, in which patients received 10 intradermal sessions over 4 months. The manufacturer reports the study found reduced hair shedding and increased terminal hair count.
How many sessions of Pluryal Hair Density are needed?
The clinical study cited by the manufacturer used 10 intradermal sessions over 4 months, though the manufacturer does not state this as a universal treatment protocol for all patients.
What pack size is Pluryal Hair Density supplied in?
Pluryal Hair Density is supplied as a prefilled 2 mL syringe with 2 x 30G needles, per the manufacturer.
More from MD Skin solutions Laboratoires
Clinic alternatives
Pick up where you left off
Pluryal Hair Density
Pluryal Hair Density is a sterile, ready-to-use injectable polynucleotide (PN) biostimulator, CE-marked and reserved for medical practitioners only. Pluryal Hair Density polynucleotides are formulated for scalp and hair regeneration, indicated for hair loss conditions such as androgenetic alopecia and telogen effluvium, as well as post-hair transplantation support. The product contains 15 mg of polynucleotides per 2 mL syringe (7.5 mg/mL) and is intended strictly for professional use.
Key Benefits of Pluryal Hair Density
- Supports follicular stimulation through activation of dermal papilla cell activity
- Improves hair cycle dynamics, increasing the anagen/telogen ratio and reducing premature miniaturisation
- Provides anti-inflammatory action, reducing inflammatory mediators in the scalp
- Supports microcirculation, enhancing local perfusion, oxygenation and nutrient supply
- Promotes structural reinforcement around the follicle bulge, helping reduce hair shedding
- CE-marked medical device for professional use
Indications and Professional Use
Main indications
- Androgenetic alopecia
- Telogen effluvium
- Post-hair transplantation support
- Adjuvant therapy after hair transplantation
- Adjuvant therapy with LED light and PRP
Professional use
Pluryal Hair Density is for professional use only, reserved for medical practitioners. It is administered by intradermal injection into the scalp, using microbolus, multi-puncture or linear threading technique for diffuse areas. It is indicated for androgenetic alopecia, telogen effluvium, post-hair transplantation support, and as an adjuvant therapy after hair transplantation or alongside LED light and PRP treatment.
Treatment areas
- Scalp
- Eyebrows
- Beard
- Frontotemporal region
- Mid-scalp
- Vertex
Patient profile
Suitable for adult men and women presenting with androgenetic alopecia, telogen effluvium or scalp conditions requiring post-transplantation support, as determined by the treating practitioner following clinical assessment. The manufacturer cites a clinical study of 20 patients (10 men, 10 women; mean age 37.7 ± 8.1 years), diagnosed with androgenetic alopecia graded Hamilton-Norwood II to IV in men and Ludwig I to II in women, published in the Archives of Dermatological Research. Patients in that study received 10 intradermal injection sessions over 4 months; the manufacturer reports the study found a reduction in hair shedding, an increase in terminal hair count, and improvement in hair thickness and density parameters, with an excellent safety profile.
How Pluryal Hair Density Works
Pluryal Hair Density works through polynucleotides at 7.5 mg/mL, injected intradermally into the scalp to activate metabolic pathways and A2A purinergic receptors that promote dermal papilla cell activity. This supports improved hair cycle dynamics, reduces inflammatory mediators, enhances local microcirculation, and promotes structural reinforcement around the follicle bulge - together supporting scalp and hair regeneration in androgenetic alopecia, telogen effluvium and post-transplantation recovery.
Why Order From Allpara
Allpara offers genuine, verified PLURYAL products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
What concentration of polynucleotides does Pluryal Hair Density contain?
Pluryal Hair Density contains 15 mg of polynucleotides per 2 mL syringe, a concentration of 7.5 mg/mL, per the manufacturer.
Which areas does Pluryal Hair Density treat?
Pluryal Hair Density treats the scalp, eyebrows and beard, including the frontotemporal region, mid-scalp and vertex, for androgenetic alopecia, telogen effluvium and post-hair transplantation support.
At what depth is Pluryal Hair Density injected?
Pluryal Hair Density is injected intradermally into the scalp, using microbolus, multi-puncture or linear threading technique for diffuse areas, per the manufacturer.
Is there clinical evidence for Pluryal Hair Density?
The manufacturer cites a clinical study of 20 patients with androgenetic alopecia, published in the Archives of Dermatological Research, in which patients received 10 intradermal sessions over 4 months. The manufacturer reports the study found reduced hair shedding and increased terminal hair count.
How many sessions of Pluryal Hair Density are needed?
The clinical study cited by the manufacturer used 10 intradermal sessions over 4 months, though the manufacturer does not state this as a universal treatment protocol for all patients.
What pack size is Pluryal Hair Density supplied in?
Pluryal Hair Density is supplied as a prefilled 2 mL syringe with 2 x 30G needles, per the manufacturer.